TYSALRIX Trademark

Trademark Overview


On Thursday, November 2, 2000, a trademark application was filed for TYSALRIX with the United States Patent and Trademark Office. The USPTO has given the TYSALRIX trademark a serial number of 78033402. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, April 17, 2003. This trademark is owned by SmithKline Beecham Biologicals S.A.. The TYSALRIX trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use
tysalrix

General Information


Serial Number78033402
Word MarkTYSALRIX
Filing DateThursday, November 2, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, April 17, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 24, 2001

Trademark Statements


Goods and Servicesvaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 21, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSmithKline Beecham Biologicals S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameSmithKline Beecham Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Thursday, December 11, 2003ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 12, 2003EXTENSION 2 GRANTED
Wednesday, October 9, 2002EXTENSION 2 FILED
Wednesday, October 9, 2002TEAS EXTENSION RECEIVED
Thursday, April 18, 2002EXTENSION 1 GRANTED
Friday, April 12, 2002EXTENSION 1 FILED
Friday, April 12, 2002TEAS EXTENSION RECEIVED
Tuesday, October 16, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 24, 2001PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2001NOTICE OF PUBLICATION
Monday, April 9, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 5, 2001ASSIGNED TO EXAMINER

Related Keywords


tysalrix human vaccines